Belgium & Norway Life Sciences Day: Exploring the future of health and biotech
17 June 2024
Join us for the Belgium & Norway Life Sciences Day conference, part of the Belgian Economic Mission in Oslo, uniting industry leaders and researchers to shape the future of health and biotech collaboration.
The conference is one of the key events scheduled during the Belgian Economic Mission which will take place in Oslo from the 17th to the 19th of June and will be presided over by H.R.H. Princess Astrid of Belgium. The mission is jointly organised by the Belgian Foreign Trade Agency and three regional institutions: Wallonia Export & Investment Agency, Flanders Investment & Trade, and Hub. Brussels.
The programme for the day has been developed with the help of and contributions from Innovation Norway, LMI, The Life Science Cluster, Norway Health Tech, Oslo Cancer Cluster and Norwegian Smart Care Cluster.
This conference will bring together esteemed keynote speakers, professionals and researchers from both countries to explore the diverse fields of health and life sciences, from production of innovative biologics to AI-driven patient care.
Throughout the day, the event aims to uncover synergies, share insights and build collaborations that will drive innovation in this dynamic field. Additionally, attendees will have the opportunity to engage with leading companies and fellow participants, creating a vibrant environment for networking and knowledge exchange.
For more information about the event and programme, visit the official website here.
Important conditions
Companies must adhere to standards for responsible business conduct, including Environmental, Social, and Governance (ESG) criteria.
Participants are expected to operate in accordance with the UN Guiding Principles on Business and Human Rights and the OECD Guidelines for Multinational Enterprises on Responsible Business Conduct. This entails conducting business responsibly, respecting human rights, ensuring decent working conditions, safeguarding environmental considerations, and actively preventing corruption.
Companies must carry out their own due diligence assessments (risk assessments) to identify, prevent, and mitigate potential adverse impacts.